MEDESIS PHARMA FIN DU RECRUTEMENT DES 68 PATIENTS ... - Zonebourse.com
| ALMDP Stock | EUR 0.37 0.01 2.63% |
Slightly above 61% of Medesis Pharma's investor base is looking to short. The analysis of current outlook of investing in Medesis Pharma SA suggests that many traders are alarmed regarding Medesis Pharma's prospects. Medesis Pharma's investing sentiment overview a quick insight into current market opportunities from investing in Medesis Pharma SA. Many technical investors use Medesis Pharma SA stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Medesis |
MEDESIS PHARMA FIN DU RECRUTEMENT DES 68 PATIENTS ... Zonebourse.com
Read at news.google.com
 |
Medesis Pharma Fundamental Analysis
We analyze Medesis Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medesis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medesis Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Medesis Pharma is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Medesis Pharma SA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Medesis Pharma stock to make a market-neutral strategy. Peer analysis of Medesis Pharma could also be used in its relative valuation, which is a method of valuing Medesis Pharma by comparing valuation metrics with similar companies.
Peers
Medesis Pharma Related Equities
| ALHRS | Hydrogen Refueling | 0.88 | ||||
| OSE | OSE Pharma | 0.15 | ||||
| ABVX | Abivax SA | 0.98 | ||||
| ALBPS | Biophytis | 3.23 |
Additional Tools for Medesis Stock Analysis
When running Medesis Pharma's price analysis, check to measure Medesis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medesis Pharma is operating at the current time. Most of Medesis Pharma's value examination focuses on studying past and present price action to predict the probability of Medesis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medesis Pharma's price. Additionally, you may evaluate how the addition of Medesis Pharma to your portfolios can decrease your overall portfolio volatility.